Literature DB >> 2354189

A rapid selection for animal cell mutants with defective peroxisomes.

O H Morand1, L A Allen, R A Zoeller, C R Raetz.   

Abstract

Chinese hamster ovary (CHO) cells take up and incorporate 9-(1'-pyrene)nonanol (P9OH) into phospholipids and neutral lipids. Exposure of P9OH-labeled cells to long wavelength ultraviolet (UV) light causes cell death, because excitation of the pyrene moiety generates reactive oxygen species. CHO mutant cells deficient in plasmalogen biosynthesis and peroxisome assembly (Zoeller, R.A. and Raetz, C.R.H. (1986) Proc. Natl. Acad. Sci. USA 83, 5170-5174) are much more resistant to P9OH/UV treatment than are wild-type cells. This phenotype is explained by a 7.5-fold reduction of P9OH incorporation into the ethanolamine-linked phospholipids in the mutant cells and 2.4- to 6-fold reduction of P9OH incorporation into all other phospholipids and triglycerides, suggesting a general defect in fatty alcohol metabolism. [U-14C]Hexadecanol incorporation into the phospholipids of the mutant cells is also impaired. In contrast, the fatty acid analog, 9-(1'-pyrene)nonanoic acid, is incorporated into cells two times more rapidly by the mutants than by the wild type. Resistance to P9OH/UV treatment affords a simple, new method for the selection of animal cell mutants defective in peroxisome biogenesis.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2354189     DOI: 10.1016/0304-4165(90)90066-6

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  11 in total

Review 1.  Targeting of proteins into the peroxisomal matrix.

Authors:  S Subramani
Journal:  J Membr Biol       Date:  1992-01       Impact factor: 1.843

Review 2.  Peroxisome Biogenesis Disorders.

Authors:  Masanori Honsho; Kanji Okumoto; Shigehiko Tamura; Yukio Fujiki
Journal:  Adv Exp Med Biol       Date:  2020       Impact factor: 2.622

3.  Isolation of a Chinese hamster fibroblast variant defective in dihydroxyacetonephosphate acyltransferase activity and plasmalogen biosynthesis: use of a novel two-step selection protocol.

Authors:  N Nagan; A K Hajra; L K Larkins; P Lazarow; P E Purdue; W B Rizzo; R A Zoeller
Journal:  Biochem J       Date:  1998-05-15       Impact factor: 3.857

4.  Peroxisome targeting signal type 1 (PTS1) receptor is involved in import of both PTS1 and PTS2: studies with PEX5-defective CHO cell mutants.

Authors:  H Otera; K Okumoto; K Tateishi; Y Ikoma; E Matsuda; M Nishimura; T Tsukamoto; T Osumi; K Ohashi; O Higuchi; Y Fujiki
Journal:  Mol Cell Biol       Date:  1998-01       Impact factor: 4.272

5.  The peroxin pex3p initiates membrane assembly in peroxisome biogenesis.

Authors:  K Ghaedi; S Tamura; K Okumoto; Y Matsuzono; Y Fujiki
Journal:  Mol Biol Cell       Date:  2000-06       Impact factor: 4.138

6.  Human PEX1 cloned by functional complementation on a CHO cell mutant is responsible for peroxisome-deficient Zellweger syndrome of complementation group I.

Authors:  S Tamura; K Okumoto; R Toyama; N Shimozawa; T Tsukamoto; Y Suzuki; T Osumi; N Kondo; Y Fujiki
Journal:  Proc Natl Acad Sci U S A       Date:  1998-04-14       Impact factor: 11.205

7.  A fibroblast cell line defective in alkyl-dihydroxyacetone phosphate synthase: a novel defect in plasmalogen biosynthesis.

Authors:  N Nagan; A K Hajra; A K Das; H W Moser; A Moser; P Lazarow; P E Purdue; R A Zoeller
Journal:  Proc Natl Acad Sci U S A       Date:  1997-04-29       Impact factor: 11.205

8.  Mutations in novel peroxin gene PEX26 that cause peroxisome-biogenesis disorders of complementation group 8 provide a genotype-phenotype correlation.

Authors:  Naomi Matsumoto; Shigehiko Tamura; Satomi Furuki; Non Miyata; Ann Moser; Nobuyuki Shimozawa; Hugo W Moser; Yasuyuki Suzuki; Naomi Kondo; Yukio Fujiki
Journal:  Am J Hum Genet       Date:  2003-07-08       Impact factor: 11.025

9.  Animal cell mutants represent two complementation groups of peroxisome-defective Zellweger syndrome.

Authors:  N Shimozawa; T Tsukamoto; Y Suzuki; T Orii; Y Fujiki
Journal:  J Clin Invest       Date:  1992-11       Impact factor: 14.808

10.  PEX12, the pathogenic gene of group III Zellweger syndrome: cDNA cloning by functional complementation on a CHO cell mutant, patient analysis, and characterization of PEX12p.

Authors:  K Okumoto; N Shimozawa; A Kawai; S Tamura; T Tsukamoto; T Osumi; H Moser; R J Wanders; Y Suzuki; N Kondo; Y Fujiki
Journal:  Mol Cell Biol       Date:  1998-07       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.